Page last updated: 2024-08-26

mci 9038 and Kidney Failure, Chronic

mci 9038 has been researched along with Kidney Failure, Chronic in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's7 (70.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rondina, MT; Varedi, A; Walker, A; Yarbrough, PM1
Agishi, T; Akizawa, T; Hirasawa, Y; Matsui, N; Ota, K1
Hara, T; Jojima, K; Naito, K; Takai, K; Takeuchi, K1
Ferrell, J; Grossman, EJ; Hammes, MS; Hursting, MJ; Murray, PT; Reddy, BV; Shamp, TR; Swan, SK; Tang, I; Trevino, S1
Grossman, EJ; Hursting, MJ; Murray, PT; Reddy, BV; Trevino, SA1
Charest, AF; Geerts, WH; Grand'Maison, A1
Funaki, B; Van Ha, TG; Zangan, SM1
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J1
Matsuo, M; Matsuo, T; Sakai, R; Yamada, T1
Matsuo, O; Matsuo, T; Nakao, K; Yamada, T1

Reviews

1 review(s) available for mci 9038 and Kidney Failure, Chronic

ArticleYear
Anticoagulant use in patients with chronic renal impairment.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Volume: 5, Issue:5

    Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudins; Humans; Kidney Failure, Chronic; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Warfarin

2005

Trials

2 trial(s) available for mci 9038 and Kidney Failure, Chronic

ArticleYear
A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease.
    Kidney international, 2004, Volume: 66, Issue:6

    Topics: Adult; Aged; Anticoagulants; Arginine; Cross-Over Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Renal Dialysis; Sulfonamides; Thrombosis

2004
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:10

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Drug Administration Schedule; Female; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Prospective Studies; Renal Replacement Therapy; Retrospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome

2005

Other Studies

7 other study(ies) available for mci 9038 and Kidney Failure, Chronic

ArticleYear
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:11

    Topics: Anticoagulants; Antithrombins; Arginine; End Stage Liver Disease; Heparin; Humans; Kidney Failure, Chronic; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia

2012
Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8

    Topics: Aged; Anticoagulants; Antithrombin III Deficiency; Arginine; Female; Hematocrit; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Renal Dialysis; Retrospective Studies; Sulfonamides

2003
Intraoperative management of a congenital antithrombin deficient patient on chronic hemodialysis.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:1

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Benzamidines; Guanidines; Humans; Intraoperative Care; Kidney Failure, Chronic; Male; Parathyroidectomy; Pipecolic Acids; Renal Dialysis; Sulfonamides

2004
Systemic anticoagulation with argatroban during arteriovenous dialysis graft thrombolysis.
    Journal of vascular and interventional radiology : JVIR, 2006, Volume: 17, Issue:10

    Topics: Anticoagulants; Arginine; Hemofiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Renal Dialysis; Sulfonamides; Thrombolytic Therapy; Thrombosis

2006
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    American journal of hematology, 2008, Volume: 83, Issue:3

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2008
Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.
    Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1991, Volume: 19, Issue:1

    Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Antithrombins; Arginine; Heparin; Humans; Kidney Failure, Chronic; Male; Peptide Hydrolases; Pipecolic Acids; Renal Dialysis; Sulfonamides

1991
Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit.
    Thrombosis research, 1986, Jan-01, Volume: 41, Issue:1

    Topics: Adult; Aged; Anticoagulants; Arginine; beta-Thromboglobulin; Blood Platelets; Female; Heparin; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Renal Dialysis; Sulfonamides

1986